Detalhe da pesquisa
1.
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.
Cancer
; 125(12): 2123-2129, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861098
2.
Una Mano Amiga: Pilot Test of a Patient Navigator Program for Southwest New Mexico.
J Cancer Educ
; 34(1): 173-179, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28956318
3.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
; 15(6): 624-630, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141714
4.
Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort.
Cancer
; 123(2): 327-335, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696377
5.
Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.
Support Care Cancer
; 25(4): 1191-1199, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27928641
6.
The challenge of measuring intra-individual change in fatigue during cancer treatment.
Qual Life Res
; 26(2): 259-271, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469506
7.
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Lancet Oncol
; 17(11): e510-e514, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769798
8.
Intermittent versus continuous androgen deprivation in prostate cancer.
N Engl J Med
; 368(14): 1314-25, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23550669
9.
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622.
Breast Cancer Res Treat
; 159(1): 87-95, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27475087
10.
Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.
Qual Life Res
; 24(10): 2333-44, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935353
11.
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
Lancet Oncol
; 14(9): 893-900, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871417
12.
Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.
J Sex Med
; 10(12): 3135-43, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118980
13.
Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective.
Support Care Cancer
; 21(12): 3461-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23955026
14.
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.
Qual Life Res
; 22(8): 1889-905, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23288613
15.
Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
J Natl Cancer Inst
; 115(4): 437-446, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625510
16.
A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Oncologist
; 17(9): 1180-90, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22723506
17.
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
Med Care
; 50(12): 1060-70, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22922434
18.
Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.
Value Health
; 15(5): 716-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22867781
19.
Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer.
Qual Life Res
; 21(5): 765-75, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21922153
20.
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
BJU Int
; 108(6): 851-6; discussion 856-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21244609